Larimar Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Larimar Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Larimar Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 63.8M shares, a 45.3% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 43.9M shares, a 70.4% increase from 2022.
  • Larimar Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 25.8M shares, a 50.1% increase from 2021.
  • Larimar Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 17.2M shares, a 44.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 63.8M +19.9M +45.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 63.8M +19.9M +45.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 53.6M +9.66M +22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 43.9M +18.1M +70.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 43.9M +21.7M +97.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 43.9M +25.6M +139% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 43.9M +25.6M +139% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 25.8M +8.6M +50.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 22.2M +3.94M +21.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 18.3M +2.34M +14.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 18.3M +2.34M +14.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 17.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 18.3M +2.3M +14.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 16M +6.61M +70.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 16M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 16M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 9.38M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.